Introduction
Lysophosphatidic acid (LPA; 1-acyl-2-sn-glycerol-3-phosphate) and sphingosine-1-phosphate (S1P) are structurally related phospholipids that evoke homoneand growth factor-like responses in numerous cell types by activating their cognate G protein-coupled receptors (GPCRs), provisionally termed the`Edg' (for`endothelial dierentiation gene') or`LP' (for`lysophospholipid') receptor subfamily (see below). The Edg/LP receptor subfamily can be subdivided into two subgroups: receptors that are speci®c for LPA (three members) and those that bind S1P with high-anity (®ve members). A remarkably wide variety of cellular responses to LPA and S1P has been documented to date, including rapid cytoskeletal reorganization, ionic conductance changes, alterations in (tumor) cell migration, inhibition of cell ± cell communication, stimulation of cell proliferation and suppression of apoptosis (for review see Moolenaar et al., 1997; Moolenaar, 1999) . From a signal transduction point of view, LPA serves as the prototypic GPCR agonist that activates the small GTPases Ras (via G i ) and RhoA (via G 12/13 ) to initiate mitogenic signaling and to regulate the actin cytoskeleton, respectively. In this review, we will focus on how the Ras-MAPK pathway is activated and regulated by LPA and other GPCR agonists.
LPA and S1P: intercellular lipid mediators acting on speci®c GPCRs
The best known source of extracellular LPA and S1P are platelets, which release LPA and S1P following their activation (Eichholtz et al., 1993; Yatomi et al., 1995) . Since they are products of the blood coagulation cascade, LPA and S1P are likely to promote wound healing by stimulating cell migration and proliferation at sites of injury. LPA can also be produced extracellularly through the action of secreted phospholipases, type A2 and D (Fourcade et al., 1995; van Dijk et al., 1998) . Furthermore, LPA accumulation in ascitic uid from cancer patients has been implicated in the pathogenesis of intraperitoneal cancer (Xu et al., 1995; Westermann et al., 1998) . However, it is becoming clear that, in addition to their role in pathological situations, LPA and S1P serve normal, as-yet-unknown physiological functions related to morphogenesis, growth, dierentiation and survival. This notion is supported by the wide distribution of LPA and S1P receptor transcripts in both embryonic and adult tissues and, more directly, by recent genetic studies in experimental animals, as will be outlined below.
Since the ®rst isolation a cDNA encoding a functional LPA receptor, now known as Edg-2 or LP A1 (Hecht et al., 1996) , the Edg/LP family has expanded rapidly and by now consists of eight members. Edg-2, Edg-4 and Edg-7 (or LP A1-3 ) are LPA receptors, while Edg-1, Edg-3, Edg-5, Edg-6 and Edg-8 (or LP B1-5 ) have been characterized as speci®c receptors for S1P (for review see Chun 1999; Goetzl and An, 1999; Moolenaar 1999; Lynch and Im, 1999; Contos et al., 2000a) . Edg/LP receptors are widely and dierentially expressed in embryonic and adult tissues as well as in numerous cell lines. Their closest relatives are the cannabinoid receptors (approximately 30% sequence homology), whose ligands are arachidonic acid derivatives.
Recent genetic studies have revealed the importance of LPA/S1P receptor signaling in normal development. Targeted deletion of an LPA receptor (Edg-2/LP A1 ) gene in mice results in about 50% neonatal lethality, with surviving animals showing reduced size and other abnormalities, while cortical lp A1 (7 / 7 ) neuroblasts in culture lack normal migratory and proliferative responses to LPA (Contos et al., 2000b) . Furthermore, disruption of an S1P receptor (Edg-1/LP B1 ) gene reveals that S1P signaling is essential for vascular maturation (Liu et al., 2000) , while a mutated S1P receptor-like gene in zebra®sh causes profound defects in heart development (Kupperman et al., 2000) . Future molecular genetic studies will undoubtedly provide new insights into the normal biological functions of LPA and S1P and their cognate GPCRs.
LPA and S1P receptors can couple to at least three distinct classes of G proteins, G i , G q and G 12/13 , to mediate their cellular eects , Moolenaar, 1999 Pyne and Pyne, 2000) . However, a complete and consistent picture of which individual Edg/ LP receptor member couples to which G protein-eector route has not yet been established. The delineation of endogenous LPA or S1P signaling pathways is complicated, however, as multiple Edg/LP receptor transcripts are often expressed in one cell type and subtype-selective receptor antagonists are not yet available.
The Ras-MAPK cascade LPA and thrombin were the ®rst GPCR agonists shown to rapidly stimulate Ras-GTP accumulation in quiescent mammalian cells . In those years, when the Ras-Raf-MAPK connection was just beginning to emerge, this ®nding came somewhat as a surprise, since activation of the Ras protooncogene product had normally been associated with receptor tyrosine kinase (RTK) signaling rather than GPCR signaling.
Activation of the Ras-MAPK pathway can lead to the nuclear translocation of MAPK followed by gene transcription and cell cycle progression. While many GPCRs and receptor protein tyrosine tyrosine kinases (RTKs) can activate the MAPK pathway, only those that induce sustained (as opposed to transient) MAPK activation are thought to be capable of driving quiescent cells into S phase (Brunet et al., 1999 , and references therein). The early transient phase of MAPK activation is probably fundamental to housekeeping functions, such as rapid stimulation of cellular metabolism and early gene transcription, while a second late phase of MAPK activity is required for cell cycle entry and progression through G1. Most likely, signal attenuation mechanisms such as receptor desensitization and receptor internalization kinetics determine the extent to which GPCRs and other receptors can mediate prolonged MAPK activation and induce S phase entry. For example, a desensitization-defective mutant GPCR mediates sustained MAPK activation and stimulates cell proliferation, whereas the wild-type GPCR mediates only transient signaling and is not mitogenic (Alblas et al., 1995 (Alblas et al., , 1996 .
The mechanism by which RTKs, particularly the prototypic epidermal growth factor (EGF) receptor, activate Ras signaling is now reasonably well understood (for review see Schlessinger, 2000) . These receptors undergo ligand-induced dimerization and cross-phosphorylation, and the formation of phosphotyrosine sites on the receptor leads to recruitment of the adaptor protein Grb2 in complex with the guanine nucleotide exchange factor (GEF) Sos. This sequence of events is supported by both biochemical and genetic evidence (Cheng et al., 1998; Clark et al., 1992; Olivier et al., 1993; Simon et al., 1993) . For a full mitogenic response to occur, however, active Ras-GTP needs to couple to various eector pathways (Rodriguez-Viciana et al., 1997; White et al., 1995; Gutkind, 1998; Gille and Downward, 1999) . A key downstream eector of Ras is the Ser/Thr kinase c-Raf. Its regulation is quite complex, as it involves various protein and lipid kinases and scaolding proteins (Hagemann and Rapp, 1999; Yuryev and Wennogle, 1998) . Once activated, Raf phosphorylates the MAPK/ERK kinase (MEK) which in turn phosphorylates and activates the p42 and p44 MAPKs (also termed ERK1/2).
G i -mediated Ras activation and intermediate tyrosine kinase activity
As mentioned above, LPA mimics EGF in rapidly stimulating Ras-GTP accumulation in quiescent ®bro-blasts . Ras activation was fully inhibited by pertussis toxin (PTX), yet not secondary to G i -mediated inhibition of adenylyl cyclase. Ras activation was not observed with PLCactivating agonists such as endothelin, nor with Ca 2+ -ionophore or protein kinase C (PKC)-activating phorbol ester . Soon thereafter, it was shown that a2-adrenergic receptors could similarly activate Ras via G i (Alblas et al., 1993) , consistent with the mitogenic potential of a2 agonists in certain cell types and suggesting that Ras activation may be a common event in the action of G i -coupled receptors. Intriguingly, LPA-and thrombin-induced Ras activation was found to be inhibited by protein tyrosine kinase inhibitors, at doses that did not aect EGF-induced Ras activation , Hordijk et al., 1994a , suggesting that G i signals Ras activation via intermediary tyrosine kinase activity. By analogy to EGF receptor signaling, LPA and other GPCR agonists were thought to induce phosphotyrosine-SH2 domain interactions to recruit the Grb2-Sos exchange factor complex to the plasma membrane. Several studies indicate that the bg subunits released from G i , rather than Ga i itself, initiate the MAPK cascade reviewed by Luttrell et al., 1997) , but a molecular target of bg that acts upstream of Ras has not been rigorously de®ned to date.
The search for the identity of the tyrosine kinase(s) that couple(s) G i to Ras activation has been much more dicult and confusing than originally anticipated. Part of the confusion is due to the fact that many dierent cell types and dierent stimuli have been studied, with sometimes apparently contradictory results. While Ras activation mechanisms may dier from cell type to cell type, an unequivocal pathway Gi ? tyrosine kinase(s) ? Gbr2/SOS ? Ras has not been established for a given cell type. Attractive candidates for linking G i to Ras activation are c-Src and related protein tyrosine kinases. Indeed, MAPK activation by LPA and other GPCR agonists is inhibited by Src kinase inhibitors and by expression of the C-terminal Src kinase (CSK), a negative regulator of Src activity . It should be mentioned, however, that most studies have used MAPK activation as a read-out, rather than the activation state of Ras itself. In mutant B lymphocytes that lack the Srcrelated tyrosine kinase Lyn or Bruton's tyrosine kinase (Btk), G i -mediated MAPK activation is abrogated, but whether these kinases actually connect G i to Ras activation is not clear (Wan et al., 1996 (Wan et al., , 1997 .
Concomitant with Ras activation, LPA induces rapid tyrosine phosphorylation of various substrates, mainly focal adhesion proteins, in serum-starved ®broblasts (Hordijk et al., 1994a) . However, these tyrosine phosphorylations are resistant to PTX (except for MAPK tyrosine phosphorylation) and, hence, do not play a role in G i -mediated Ras activation. More recently, the Grb2-bound dynamin GTPase (p100), a key regulator of endocytosis, was found to be tyrosine phosphorylated by LPA in a PTX-sensitive manner (Kranenburg et al., , 1999a , but whether this represents a critical upstream event in Ras activation remains unclear.
There is currently much interest in the possibility that RTKs, particularly the EGF receptor, may connect GPCRs to the MAPK cascade. Consistent with this notion, various GPCRs such as those for LPA, thrombin and endothelin, can mediate rapid tyrosine phosphorylation of the EGF receptor (`transactivation') concomitant with tyrosine kinase-dependent MAPK activation (Daub et al., 1996;  for review see Carpenter, 1999) . RTK transactivation, with subsequent recruitment of signaling intermediates, is therefore thought to be a key step in connecting GPCRs the MAPK cascade (but, again, the activation state of Ras was not measured in those studies). A very recent scenario holds that a GPCR-regulated transmembrane metalloprotease cleaves the proHB-EGF precursor at the cell surface, thereby activating the EGF receptor in a classic autocrine manner (Prenzel et al., 1999) . Yet, it is becoming increasingly clear that there is no strict correlation between EGFR transactivation and Ras activation by GPCRs. In several cases, EGFR transactivation is insensitive to PTX whereas Ras activation is fully inhibited by the toxin (Kranenburg and Moolenaar, unpublished observations). In fact, EGFR transactivation has been reported to require Ca 2+ and/or PKC (reviewed by Carpenter, 1999) , which points to involvement of the PTXinsensitive G q -PLC pathway. Other evidence indicates a role for the Ca 2+ -dependent Pyk2 tyrosine kinase in EGFR transactivation. Pyk2 can mediate MAPK activation in neuronal PC12 cells (Dikic et al., 1996; Lev et al., 1995) . In LPA-stimulated ®broblasts, Pyk2 associates with and activates c-Src. Using an elegant and powerful genetic approach, Schlessinger and coworkers (Andreev et al., 2001) have shown that the Pyk2-Src complex is essential for LPA-induced phosphorylation of the EGF receptor, but not for Ras-MAPK activation. These authors found that the EGF receptor is dispensable for LPA-induced MAPK activation in ®broblasts, as are all three Src family kinases and Pyk2 (Andreev et al., 2000) . One must conclude that, although EGF receptor transactivation is a possible pathway for GPCRs to feed into downstream signaling events, it does not seem to represent a universal link between G i and Ras activation. While the search for G i -regulated tyrosine kinases upstream of Ras ought to continue, one should consider the possibility that GPCR-mediated Ras activation may actually depend on basal, rather than stimulated, tyrosine kinase activity.
Ga i and Ga q pathways
In addition to G i -derived bg subunits Luttrell et al., 1997) , the corresponding a subunits might also contribute to MAPK activation. Activated Ga i directly binds to and inhibits adenylate cyclase, thereby lowering cytosolic cAMP levels. Since a rise in cAMP inhibits the Ras-MAPK pathway, apparently at the level of Ras-Raf interaction (Burgering et al., 1993; Cook and McCormick, 1993; Hordijk et al., 1994b; Wu et al., 1993) , it is conceivable that a Ga i -mediated fall in cAMP levels may positively in¯uence Ras-Raf coupling. This possibility remains to be examined.
Furthermore, Ga i can regulate the Ras-related GTPase Rap1, originally identi®ed as a suppressor of K-Ras transformation. Activated Ga i binds directly to a Rap1 GTPase activating protein, termed RapGAP-II, and thereby lowers Rap1-GTP levels, which is thought to signal MAPK activation via an as-yet-unknown pathway (Mochizuki et al., 1999 ). Yet, controversy exits as to whether Rap1 has any direct role in Ras-MAPK signaling (Zwartkruis et al., 1998). Recent ®ndings indicate that Rap1 regulates integrin-mediated cell adhesion (Caron et al., 2000; Katagiri et al., 2000; Reedquist et al., 2000) . So, perhaps Rap1 in¯uences GPCR-induced MAPK activation only in those cases where signaling proceeds indirectly via integrin`activation'.
The classic Ga q -PLC-Ca 2+ /PKC pathway can also mediate MAPK activation, either via Ras or independently of Ras. Certain Ras-speci®c GEFs can activate Ras in response to PLC-generated messengers such as Ca 2+ and diacylglycerol, which bind directly to these GEFs (Buchsbaum et al., 1996; Farnsworth et al., 1995; Ebinu et al., 1998; Mattingly et al., 1999) . In cells expressing these GEFs, Ras can thus be activated via PLC activation in a Grb2-Sos-independent manner. Furthermore, several PKC isozymes can phosphorylate and activate c-Raf independently of Ras (Schonwasser et al., 1998; Ueda et al., 1996) . PKC activation by phorbol ester leads to Ras activation in COS epithelial cells and in neonatal myocytes Chiloeches et al., 1999) , but this pathway apparently does not function in ®broblasts . PKC-mediated Ras activation is probably Sosindependent and does not require tyrosine kinase activity (Kranenburg et al., 1999b) . Perhaps PKC activates Ras via inactivation of RasGAP, as was originally proposed for phorbol ester-induced Ras activation in T cells (Downward et al., 1990) .
Involvement of PI-3-kinase
Several studies have shown that pharmacological inhibition of phosphatidylinositol-3-kinase (PI-3-K) activity suppresses Ras activation and MAPK phosphorylation by both LPA and EGF, but the underlying mechanisms are probably quite diverse in nature and certainly far from clear Kranenburg et al., 1997; Wennstrom and Downward, 1999) . One attractive possibility is that PI-3-K-produced lipids interact with the pleckstrin homology domain of the Sos exchanger, aiding its colocalization with Ras at the plasma membrane, although this remains to be demonstrated.
The discovery of a bg-activated PI-3-K isozyme (PI-3-Kg) (Stephens et al., 1994 (Stephens et al., , 1997 Stoyanov et al., 1995) , together with the apparent role of G i (bg) in MAPK activation, suggest that this lipid kinase may functions in the G i -Ras-MAPK route. Indeed, GPCR stimulation of MAPK is attenuated in PI-3-Kgde®cient neutrophils (Sasaki et al., 2000) . Most likely, the intrinsic protein kinase rather than the lipid kinase activity of PI-3-Kg mediates MAPK activation downstream of Ras by stimulating MEK phosphorylation (Bondeva et al., 1998) . It should be emphasized that this model is unlikely to hold for non-haematopoetic cells, since expression of the PI-3-Kg isoform is restricted to neutrophils.
PI-3-K activity has also been positioned upstream of Ras Hu et al., 1995; Lopez-Ilasaca et al., 1997 ). An interesting explanation for the eects of pharmacological PI-3-K inhibitors on Ras-MAPK activation has been put forward by Wennstrom and Downward (1999) , who reported that Ras activation depends on basal, rather than stimulated, PI-3-K activity in the action of EGF and possibly also that of LPA. Strong elevation of PI-3-K lipid product levels by expression of membrane-targeted p110-alpha was never sucient to activate either Ras or MAPK in Cos epithelial cells. This indicates that the inhibitory eects of PI-3-K inhibitors re¯ect a permissive rather than an upstream regulatory role for PI-3-K in Ras activation.
More recently, another possible link between PI-3-K activity and Ras-Raf-MAPK activation has emerged. It was shown that PI-3-K activation following integrin stimulation regulates p21-activated kinase (PAK), presumably via PIP3-dependent exchange factors for Rac and/or Cdc42 (Chaudhary et al., 2000) . PAK can activate c-Raf (King et al., 1998) , whilst Cdc42 can regulate RasGRF, which reveals additional modes of cross-talk between Ras and Rho family GTPases (Arozarena et al., 2000) . These newly uncovered links between PI-3-K and Ras/Raf activities may help to explain how PI-3-K participates in GPCR stimulation of the MAPK cascade.
Finally, as will be discussed below, activation of MAPK activation is dependent on endocytic tracking (Daaka et al., 1998; Kranenburg et al., 1999b; Vieira et al., 1996) , a process that is known to require PI-3-K activity (Simonsen et al., 1998) . The dependence of MAPK activation on PI-3-K activity may therefore re¯ect the involvement of endocytic processes. In conclusion, it is clear that the precise role of PI-3-K activity in MAPK activation is not easily explained and strongly depends on cell type and receptor stimulus.
Receptor-mediated endocytosis and MAPK activation
Most GPCRs, in common with RTKs, undergo rapid ligand-induced phosphorylation and internalization from the cell surface. This receptor-mediated, clathrin-dependent endocytosis is regulated by the dynamin GTPase. The importance of receptormediated endocytosis in mitogenic signaling has recently become a matter of renewed interest (for review see Leof, 2000) . A major function of receptor endocytosis is to attenuate signal generation at the cell surface. Internalization-de®cient GPCRs can still activate MAPK properly (Budd et al., 1999; Whistler and von Zastrow, 1999) , but receptor signaling kinetics are usually dramatically altered. For example, Cterminal truncation of the GPCR for neurokinin A abrogates its internalization in response to ligand stimulation and causes persistent, as opposed to transient, activation of PLC and MAPK in transfected ®broblasts (Alblas et al., 1995 (Alblas et al., , 1996 Jalink and Moolenaar, unpublished results) . Sustained signaling by the internalization-defective mutant GPCR leads to long-term stimulation of cell proliferation and even phenotypic transformation in a ligand-dependent manner (Alblas et al., 1996) . This illustrates the importance of receptor internalization and desensitization in the control of signal duration and suppression of cell transformation.
When endocytosis is inhibited by a dominantnegative version of dynamin, EGF-induced PLC activation is potentiated while, surprisingly, MAPK activation is attenuated (Viera et al., 1996) . Initially, these ®ndings were interpreted in terms of receptor internalization. However, there is now ample evidence that receptor tracking itself is not required for MAPK activation. In cells expressing dominantnegative dynamin, MAPK activation by LPA, EGF and even phorbol ester is abrogated, whereas activation of Ras, Raf and MEK is unimpaired (Kranenburg et al., 1999b) . Conversely, overexpression of wild-type dynamin potentiates LPA-and EGF-induced MAPK activation, but not MEK activation. This suggests that dynamin-driven endocytosis of activated MEK, rather than activated receptors, is a critical event in the MAPK activation cascade. These results highlight the importance of proper localization and tracking of signaling intermediates in activation of the MAPK cascade (Kranenburg et al., 1999b) . The dependence of MAPK activation on endocytosis is not found in all studies. For a recent review on this topic the reader is referred to Leof (2000) .
Role of caveolae and rafts
Many signaling molecules, including GPCRs, RTKs and components of the MAPK cascade, are found in plasma membrane subdomains that are rich in cholesterol and glycosphingolipids, the so-called`rafts' (Anderson, 1998; Pralle et al., 2000) .`Caveolae' are invaginating membrane rafts that contain caveolin, a cholesterol-binding protein that is essential for caveolar integrity. Cavealoae are thought to provide a properly structured microenvironment for ecient signal transduction (Anderson, 1993; Sargiacomo et al., 1993) . Caveolin can bind to G proteins, H-Ras and c-Src and G proteins. It has been proposed that caveolin binding attenuates the activity of these signaling intermediates (Razani et al., 2000) , which seemingly contrasts with the idea that caveolae would promote signaling. Moreover, the targeted downregulation of caveolin expression causes deregulated MAPK activation and cell transformation (Galbiati et al., 1998) . This reinforces the importance of membrane localization as a key parameter in the control of MAPK activation as well as tumor suppression. Genetic evidence in C. elegans also suggests that caveolin is a negative regulator of Ras-MAPK signaling (Scheel et al., 1999) . Recent studies indicate yet another level of complexity with respect to plasma membrane subdomains and Ras signaling. The localization of distinct Ras isoforms at the cell surface diers because of dierences in their lipid anchors (Apolloni et al., 2000; Choy et al., 1999) . Membrane cholesterol appears to be essential for signaling by H-Ras, but not by K-Ras (Roy et al., 1999) . Thus, dierential localization of Ras isoforms may determine how signaling proceeds in dierent plasma membrane microdomains. Perhaps caveolar regulation of MAPK activation depends on the particular Ras isoform that is expressed and activated in a given cell type. One may even envision a model in which dierentially localized GPCRs signal to dierent Ras isoforms, depending on their localization to a particular raft.
Concluding remarks
Our understanding of how GPCRs in general, and those for LPA in particular, regulate the Ras-MAPK pathway has increased considerably since the initial observation that LPA rapidly activate Ras in a PTXsensitive and tyrosine kinase-dependent manner in quiescent ®broblasts ). Yet, molecular dissection of the G i -Ras activation pathway has met with diculties and is more complex and diverse in nature than originally anticipated. Outstanding questions that remain to be answered include the relative contribution of Ga versus Gbg subunits, and how these individual subunits couple to downstream eectors, including tyrosine kinases, to promote GDP/GTP exchange on Ras.
As for LPA/S1P signaling, it is currently unclear which of the eight known Edg/LP receptor members can couple to Ras activation in a given cell type and, if so, through which G protein pathways. Can all Edg/LP receptor members mediate prolonged MAPK activation, which is considered a prerequisite for cell cycle progression? Or, do certain Edg/LP receptors actually couple more eectively to the Ras-related Rho GTPases to evoke rapid cytoskeletal and cell migration eects, rather than to promote proliferative responses to LPA and S1P? In neuroblastoma cells, for example, LPA and S1P rapidly activate RhoA via G 12/13 leading to dramatic neurite retraction and cell rounding (Kranenburg et al., 1999c) , accompanied by G imediated MAPK activation yet without an ensuing increase in cell proliferation (unpublished observations). Answers to these and other outstanding questions will undoubtedly emerge in the not too distant future.
